Getting latest data loading
Home / Morning Report / Morning Report – 3rd August 2026

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Morning Report - 3 August 2026

Yesterday’s UK 100 Leaders Price (p) % Chg
NatWest Group 705.8 3.2%
Polar Capital Technology Trust 626.5 2.5%
Pershing Square Holdings 3,808.0 2.4%
Metlen Energy & Metals 46.2 2.2%
BAE Systems 2,094.0 2.2%

 

Yesterday’s UK 100 Laggards Price (p) % Chg
IG Group Holdings 1,460.0 -14.4%
Melrose Industries 454.3 -4.4%
JD Sports Fashion 89.5 -4.1%
Experian 2,790.0 -3.7%
Informa 885.8 -3.1%

 

Major World Indices Price % Chg 1 Year
UK 100 INDEX 10,868 0.3% 19.8%
DOW JONES INDUS. AVG 52,485 0.5% 20.4%
DAX INDEX 25,629 0.1% 9.4%
NIKKEI 225 64,362 4.0% 57.8%
S&P/ASX 200 INDEX 8,977 0.1% 3.6%
Commodity Units Price % Chg
WTI Crude Oil (Nymex) USD/bbl. 84.67 1.29%
Brent Crude (ICE) USD/bbl. 87.93 1.21%
Gold Spot USD/t oz. 4,046 1.4%
Copper (Comex) USd/lb. 647 0.1%
The UK 100 is called to open +35 points at at 10,903. 

4 Hours; 6 Months

Click graph to enlarge

Markets Overview:


The UK 100 is called to open +35 points at at 10,903.  
Stocks in London are set to open higher on Monday as hopes for renewed US-Iran diplomacy offset caution following a joint US-Japan intervention to strengthen the yen.

US President Donald Trump said fresh negotiations with Iran will begin on Monday after he decided to hold off on military strikes in favour of pursuing a deal to end the war, now entering its sixth month.

Trump said Iran, alongside US partners Saudi Arabia, the UAE and Qatar, had urged him to delay what he claimed would have been “the biggest attack since World War II”. He said the talks would focus on reopening the Strait of Hormuz, a key route for global energy supplies, and ultimately on Iran’s denuclearisation.

Meanwhile, Iran said it was nearing an agreement with Oman over a new shipping route through the strait, where a tanker reported an explosion nearby on Sunday, underlining the continued volatility in the region.

In the US on Friday, Wall Street ended higher, with the Dow Jones Industrial Average up 0.5%, the S&P 500 up 0.7% and the Nasdaq Composite up 1.0%.

The Nikkei 225 index in Tokyo was down 1.2%, elsewhere in Asia on Monday, the Shanghai Composite fell 0.8%, while the Hang Seng index in Hong Kong edged down 0.1%, after data showed China’s manufacturing expansion lost momentum in July.

Company News & Broker Comments:

 

Company News:

AstraZeneca and Bristol-Myers Squibb are considering merging in a deal worth USD400 billion, the Financial Times reported on Sunday.  The Cambridge, England-based drug maker and its Lawrenceville, New Jersey-based peer recently held talks about a potential combination of their businesses, according to people familiar with the matter cited by the FT.

 

Easyjet – The takeover panel has agreed to extend the deadline for US investment fund Castlelake to consider a firm offer for UK airline EasyJet.  Castlelake’s 690p per share offer was recommended by the Easyjet board until Apollo came in with a 715p cash offer which the airline’s board has now recommended.  The regulator has now agreed to extend Castlelake’s deadline to 5pm on 7 August to align with Apollo’s deadline. EasyJet has been providing diligence access to both companies.  Apollo has confirmed that it would agree to satisfy any conditions relating to merger control and EU Foreign Subsidies Regulation clearances relating to the proposed transaction which has been seen as a sticking point to an airline acquisition.  The proposed offer made on 8 July represents a premium of 81% to the closing price of 394p at the close of business on 28 May, the last day prior to the offer from Castlelake submitted on 4 July.  Apollo will finance the deal from Apollo funds. Barclays has provided a letter to Apollo indicating that it is “highly confident” of being able to arrange the required debt financing for the offer.

Reporting Today:

 

UK

Senior (SNR) – 2026 Interim Results

 

US

Palantir Technologies Inc Ordinary Shares – Class A (NASDAQ:PLTR) AMC

Snap Inc Class A (NYSE:SNAP) AMC

Vertex Pharmaceuticals Inc (NASDAQ:VRTX) AMC

Reporting Tomorrow:

 

UK

BP (BP.) – Q2 2026 Results

Coca-Cola Europacific Partners (CCEP) – H1 2026 Results

ConvaTec Group (CTEC) – Interim results

Rotork (ROR) – Interim results

Smith & Nephew (SN.) – Q2/H1 2026 Results

HSBC (HSBA) – Interim Results

 

US

Ball Corp (NYSE:BALL) PMO

Caterpillar Inc (NYSE:CAT) PMO

McDonald’s Corp (NYSE:MCD) PMO

Merck & Co Inc (NYSE:MRK) PMO

Pfizer Inc (NYSE:PFE) PMO

Spotify Technology SA (NYSE:SPOT) PMO

Advanced Micro Devices Inc (NASDAQ:AMD) AMC

Amgen Inc (NASDAQ:AMGN) AMC

Arista Networks Inc (NYSE:ANET) AMC

Booking Holdings Inc (NASDAQ:BKNG) AMC

Gilead Sciences Inc (NASDAQ:GILD) AMC

Lucid Group Inc Shs (NASDAQ:LCID) AMC

Pinterest Inc Class A (NYSE:PINS) AMC

Space Exploration Technologies Cor (NASDAQ:SPCX) AMC

Upstart Holdings Inc Ordinary Shares (NASDAQ:UPST) AMC

In Focus Today:

 

US ISM Manufacturing PMI

This Week’s Ex-Dividends:

 

UK 100 companies going ex-dividend on 6th August 2026:

BT Group

Reckitt Benckiser Group

Informa

Lloyds Banking Group

Schroders

Barclays

SEGRO

Unilever

RELX

Standard Chartered

AstraZeneca

St. James’s Place

Rolls-Royce Holdings

 

UK 250 companies going ex-dividend on 6th August 2026:

Jupiter Fund Management

Telecom Plus

Man Group

Inchcape

Lancashire Holdings

Avon Technologies

Helios Towers

 

For any help you may require placing trades or in terms of market information, put a call in to our trading floor – it’s all part of the service.


Back to Top

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.


Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 69% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.